Vimian acquires animal pharmaceuticals company in the UK

January 29, 2022

Today Vimian Group signed an agreement to acquire Bova Holdings Limited (Bova), a leading companion animal health specialty pharmaceuticals company in the United Kingdom. The company offers customised specialty pharmaceuticals for companion animals.

Established in 2017, Bova offers specialty pharmaceuticals covering a wide and expanding range of product classes. The company has more than 100 specialty pharmaceutical formulations, all raw materials and products are compliant with quality standards set out by regulatory authorities and the pharmaceuticals industry. Bova serves veterinary clinics and hospitals across the UK and in ten additional European markets through an online ordering system with deliveries within 24 hours. 

Nick Bova, founder and CEO of Bova, will continue to lead the company as part of Nextmune and Vimian.

Read more:

Recent news

iBinder Group acquires REQS System

REQS System AB now becomes part of the iBinder Group and strengthens the group’s offering in property management, inspections, and controlling. The acquisition is an important step in iBinder’s goal of creating a simple platform for the property’s entire life

Read more

Odevo continues US expansion as Spectrum AM joins…

Odevo, an international leader that is driving change in the traditional property management industry, continues its rapid expansion in the US market with the addition of successful Texas-based Spectrum Association Management and five additional new brands joining the Group. These

Read more

iBinder expands outside the Nordics

Swedish Software as a Service company iBinder develops and provides the construction and real estate industries with digital solutions for efficient collaboration. The company’s core solution is a cloud-based collaboration platform that ensures efficient and easy sharing of information throughout

Read more